Prof. Mehmet BİLİCİ

Publication Network

Articles 86

1. Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters

Çağlar A. A., Hannarici Z., Buyukbayram M. E., TURHAN A., SOYLU Y., BİLİCİ M., et al.

BMC Cancer , vol.26, no.1, 2026 (SCI-Expanded, Scopus)

2. Effects of laughter yoga on symptom severity, hope, and life engagement in patients undergoing chemotherapy; a randomized controlled study

ÇIRACI YAŞAR Y., TAN M., BİLİCİ M.

European Journal of Oncology Nursing , vol.84, 2026 (SCI-Expanded, SSCI, Scopus)

3. Prognostic Nutritional Index Is Associated With Gastrointestinal Symptom Severity in Patients Receiving Chemotherapy for Gastrointestinal Cancer: A Cross-Sectional Study

Çıracı Yaşar Y., Tan M., Bilici M., Demir Z.

Asian Pacific Journal of Cancer Prevention , vol.27, 2026 (Scopus)

4. Adjuvant chemotherapy patterns and clinicopathological factors associated with survival in patients aged 70 years and older with resected stage II–III colon cancer: a single-center real-world study

HANNARİCİ Z., TURHAN A., BÜYÜKBAYRAM M. E., EBİNÇ S., ÇAĞLAR A. A., BİLİCİ M., et al.

Journal of medicine and palliative care (Online) , vol.7, no.4, pp.650-660, 2026 (TRDizin)

5. Prognostic Value of the Gustave Roussy Immune Score in Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy: A Retrospective Cohort Study

Turhan A., Büyükbayram M. E., Hannarici Z., Çağlar A. A., SOYLU Y., BİLİCİ M., et al.

Diagnostics , vol.16, no.12, 2026 (SCI-Expanded, Scopus)

6. Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study

Çağlar A. A., Hannarici Z., Büyükbayram M. E., Turhan A., SOYLU Y., BİLİCİ M., et al.

Journal of Clinical Medicine , vol.15, no.12, 2026 (SCI-Expanded, Scopus)

7. Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

Eken E., Güneyin E. A., Büyükkurt E., Yıldız F., BİLİCİ M., Ayman C. D.

Current Oncology , vol.33, no.6, 2026 (SCI-Expanded, Scopus)

8. Prognostic Value of Albumin-to-CEA Ratio in Metastatic Colorectal Cancer: A Retrospective Study

Hannarici Z., TURHAN A., Buyukbayram M. E., Çağlar A. A., BİLİCİ M., Tekin S. B., et al.

Biomedicines , vol.14, no.3, 2026 (SCI-Expanded, Scopus)

9. Parameters That May Predict NAC Effectiveness in Hormone-Positive Breast Cancer According to CPS Score

Buyukbayram M. E., Hannarici Z., TURHAN A., Çağlar A. A., Çoban Eşdur P., BİLİCİ M., et al.

Cancer Management and Research , vol.18, pp.1-9, 2026 (SCI-Expanded, Scopus)

10. New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

BÜYÜKBAYRAM M. E., HANNARİCİ Z., TURHAN A., GÖLCÜKLÜ S., ÇOBAN EŞDUR P., BİLİCİ M., et al.

DUZCE MEDICAL JOURNAL = DÜZCE TIP FAKÜLTESI DERGISI , vol.27, no.3, pp.241-247, 2025 (ESCI, Scopus, TRDizin)

11. Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

TURHAN A., Büyükbayram M. E., Hannarici Z., Çağlar A. A., BİLİCİ M., Tekin S. B.

Diagnostics , vol.15, no.24, 2025 (SCI-Expanded, Scopus)

12. Survival Comparison and Clinical Characteristics of Sunitinib and Pazopanib in the Treatment of Metastatic Renal Cell Cancer, Single Center Real-Life Data

BÜYÜKBAYRAM M. E., HANNARİCİ Z., TURHAN A., ÇAĞLAR A. A., BİLİCİ M., TEKİN S. B.

Kafkas Journal of Medical Sciences , vol.15, 2025 (TRDizin)

13. “Pre-Treatment“ and “Post-Treatment” Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Yaşar S., Kadıoğlu A., Akyildiz A., Sever N., Büyükbayram M. E., BİLİCİ M., et al.

Medicina (Lithuania) , vol.61, no.6, 2025 (SCI-Expanded, Scopus)

14. Cancer Data, Case Increase Rates and Future Prospects in the Northeastern Anatolia Region of Türkiye, a Special Region for Gastric and Esophageal Cancers in 2018-2023

ÇAĞLAR A. A., TURHAN A., ÇOBAN EŞDUR P., SOYLU Y. E., BİLİCİ M., TEKİN S. B.

Medical records-international medical journal (Online) , vol.7, no.1, pp.258-262, 2025 (TRDizin)

15. The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective Study

Buyukbayram M. E., Hannarici Z., Turhan A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., BİLİCİ M., et al.

Clinical Medicine Insights: Oncology , vol.19, 2025 (SCI-Expanded, Scopus)

16. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

Buyukbayram M. E., HANNARİCİ Z., TURHAN A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., BİLİCİ M., et al.

BMC CANCER , vol.24, no.1, 2024 (SCI-Expanded, Scopus) Sustainable Development

17. Mide kanserinde adropin ve hipoksi ile indüklenebilir faktör -1 alfa’nın önemi

ÇAĞLAR A. A., HANNARİCİ Z., BÜYÜKBAYRAM M. E., TURHAN A., ÇOBAN EŞDUR P., EĞİLMEZ E., et al.

Turkish Journal of Clinics and Laboratory , vol.15, no.3, pp.369-375, 2024 (TRDizin) Sustainable Development

18. Pembrolizumab in HER2-Positive Gastric Cancer

Janjigian Y. Y., Kawazoe A., Bai Y., Xu J., Lonardi S., Metges J. P., et al.

NEW ENGLAND JOURNAL OF MEDICINE , 2024 (SCI-Expanded, Scopus)

19. The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study-Real-world data

Cil T., Hacibekiroglu I., Uncu D., Isikdogan A., Ates O., Sendur M. A. N., et al.

JOURNAL OF CLINICAL ONCOLOGY , no.16, 2024 (SCI-Expanded, Scopus) Sustainable Development

20. Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma

TURHAN A., HANNARİCİ Z., BÜYÜKBAYRAM M. E., ÇAĞLAR A. A., ÇOBAN EŞDUR P., BİLİCİ M., et al.

Archives of Basic and Clinical Research , vol.6, no.1, pp.73-76, 2024 (TRDizin)

21. Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results

Janjigian Y. Y., Kawazoe A., Xu J., Lonardi S., Metges J., Wyrwicz L. S., et al.

JOURNAL OF CLINICAL ONCOLOGY , no.3_SUPPL, pp.286, 2024 (SCI-Expanded, Scopus)

22. Pathological complete response (pCR) to 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) with or without durvalumab (D) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

Janjigian Y. Y., Al-Batran S., Wainberg Z. A., Van Cutsem E., Molena D., Muro K., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.42, no.3_SUPPL, pp.245-246, 2024 (SCI-Expanded, Scopus)

23. Inflammatory parameters in NSCLC with driver mutation

Buyukbayram M. E., Hannarici Z., Yılmaz A., TURHAN A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., et al.

LUNG CANCER MANAGEMENT , vol.13, no.1, 2024 (ESCI, Scopus)

24. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

Buyukbayram M. E., Hannarici Z., Duzkopru Y., TURHAN A., ÇAĞLAR A. A., Esdur P. C., et al.

Breast Cancer: Targets and Therapy , vol.16, pp.329-339, 2024 (SCI-Expanded, Scopus)

25. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

Janjigian Y. Y., Kawazoe A., Bai Y., Xu J., Lonardi S., Metges J. P., et al.

LANCET , vol.402, no.10418, pp.2197-2208, 2023 (SCI-Expanded, Scopus)

26. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

HANNARİCİ Z., Yilmaz A., Buyukbayram M. E., TURHAN A., ÇAĞLAR A. A., BİLİCİ M., et al.

FUTURE ONCOLOGY , vol.19, no.4, pp.315-325, 2023 (SCI-Expanded, Scopus) Sustainable Development

27. Lipegfilgrastim may cause hyperleukocytosis

HANNARİCİ Z., YILMAZ A., Buyukbayram M. E., TURHAN A., TEKİN S. B., BİLİCİ M.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.8, pp.1902-1905, 2022 (SCI-Expanded, Scopus)

28. Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'

HANNARİCİ Z., YILMAZ A., Buyukbayram M. E., Tekin S. B., BİLİCİ M.

MELANOMA RESEARCH , vol.32, no.4, pp.302, 2022 (SCI-Expanded, Scopus)

29. The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib

Yılmaz A., Şimşek M., Hannarici Z., Buyukbayram M. E., Bilici M., Tekin S. B.

FUTURE ONCOLOGY , vol.17, no.33, pp.4545-4559, 2021 (SCI-Expanded, Scopus)

30. The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study

Akdeniz N., Kaplan M. A., Uncu D., İNANÇ M., Kaya S., DANE F., et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , vol.36, no.6, pp.1311-1319, 2021 (SCI-Expanded, Scopus) Sustainable Development

31. Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study

Koca S., Besiroglu M., Ozcelik M., Karaca M., BİLİCİ M., Hacioglu B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.27, no.3, pp.541-546, 2021 (SCI-Expanded, Scopus)

32. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M., SEYDAOĞLU G., et al.

CANCER INVESTIGATION , vol.39, pp.473-481, 2021 (SCI-Expanded, Scopus) Sustainable Development

33. Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer

YILMAZ A., TEKİN S. B., BİLİCİ M., yılmaz h.

ACTA ONCOLOGICA TURCICA , 2020 (TRDizin) Sustainable Development

34. Survival Analysis and Prognostic Factors in Prostate Cancer Patients: A Single Center Experience in Eastern Anatolia

YILMAZ A., BİLİCİ M., TEKİN S. B.

Dicle Tıp Dergisi , 2020 (TRDizin) Sustainable Development

35. Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia

YILMAZ A., Mirili C., BİLİCİ M., TEKİN S. B.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1791-1794, 2020 (SCI-Expanded, Scopus)

36. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer

YILMAZ A., TEKİN S. B., BİLİCİ M., Yilmaz H.

LUNG , vol.198, no.4, pp.695-704, 2020 (SCI-Expanded, Scopus) Sustainable Development

37. The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer

YILMAZ A., Yilmaz H., TEKİN S. B., BİLİCİ M.

BIOMARKERS IN MEDICINE , vol.14, no.9, pp.727-738, 2020 (SCI-Expanded, Scopus) Sustainable Development

38. Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations

YILMAZ A., MİRİLİ C., BİLİCİ M., TEKİN S. B.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , vol.35, no.2, pp.351-353, 2020 (SCI-Expanded, Scopus) Sustainable Development

39. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study

YILMAZ A., Mirili C., TEKİN S. B., BİLİCİ M.

IRISH JOURNAL OF MEDICAL SCIENCE , vol.189, no.1, pp.91-102, 2020 (SCI-Expanded, Scopus) Sustainable Development

40. Servikal Kanser Hastalarinin Uzun Dönem Sonuçlari: Doğu Anadolu Tek Merkez Deneyimi / Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey

MİRİLİ C., YILMAZ A., BİLİCİ M., TEKİN S. B.

Dicle Tıp Dergisi , vol.46, no.4, pp.857-865, 2019 (TRDizin) Sustainable Development

41. Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results

Mirili C., Kahraman Ç., Yılmaz A., Bilici M., Tekin S. B., Tatar A., et al.

Medical Science and Discovery , vol.6, no.12, pp.327-332, 2019 (Peer-Reviewed Journal)

42. Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

Kaplan M. A., Ozaydin S., Yerlikaya H., Karaagac M., GÜMÜŞ M., Cil T., et al.

ONCOLOGY RESEARCH AND TREATMENT , vol.42, no.10, pp.516-522, 2019 (SCI-Expanded, Scopus) Sustainable Development

43. A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII)

YILMAZ A., MİRİLİ C., BİLİCİ M., TEKİN S. B.

JOURNAL OF BUON , vol.24, no.5, pp.2127-2135, 2019 (SCI-Expanded, Scopus)

44. Rare Breast Malignancies

Yildirim N., Aldemir M. N., ŞİMŞEK M., BİLİCİ M., TEKİN S. B.

MEDICAL JOURNAL OF BAKIRKOY , vol.15, no.3, pp.232-239, 2019 (ESCI, Scopus, TRDizin) Sustainable Development

45. Relationship between 18-FDG-PET/CT and Clinicopathological Features and Pathological Responses in Patients with Locally Advanced Breast Cancers

Yildirim N., ŞİMŞEK M., Aldemir M. N., BİLİCİ M., TEKİN S. B.

EURASIAN JOURNAL OF MEDICINE , vol.51, no.2, pp.154-159, 2019 (ESCI, Scopus, TRDizin) Sustainable Development

46. Immunological Agents Used in Cancer Treatment

ŞİMŞEK M., TEKİN S. B., BİLİCİ M.

EURASIAN JOURNAL OF MEDICINE , vol.51, no.1, pp.90-94, 2019 (ESCI, Scopus, TRDizin) Sustainable Development

47. Creatinine kinase elevation and peripheral neuropathy during nivolumab treatment of a patient with metastatic renal cell carcinoma

ŞİMŞEK M., BİLİCİ M., TEKİN S. B.

INDIAN JOURNAL OF CANCER , vol.55, no.4, pp.413-414, 2018 (SCI-Expanded, Scopus)

48. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., Seker M. M., Inanc M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.14, no.3, pp.578-582, 2018 (SCI-Expanded, Scopus) Sustainable Development

49. EARLY ONSET OF RADIATION INDUCED SARCOMA: A CASE REPORT AND REVIEW OF THE LITERATURE

YILDIRIM N., ŞİMŞEK M., TÜRKELİ M., BİLİCİ M., KIZILTUNÇ ÖZMEN H.

Acta Medica Mediterranea , pp.565-568, 2017 (SCI-Expanded, Scopus)

50. Determination of Retinol and Beta-Carotene after Beta-Carotene Administration in Patients with Stomach Cancer via HPLC-DAD Method in Human Plasma

DEMİRKAYA MİLOĞLU F., ŞENOL O., KADIOĞLU Y., BİLİCİ M.

LATIN AMERICAN JOURNAL OF PHARMACY , vol.36, no.4, pp.740-749, 2017 (SCI-Expanded, Scopus) Sustainable Development

51. Gastrointestinal Stromal Tumors: A Single Center Experience

Yildirim N., ŞİMŞEK M., Aldemir M. N., BİLİCİ M., Basol Tekin S.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.32, no.1, pp.19-24, 2017 (ESCI, Scopus, TRDizin)

52. Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience

Turkeli M., Simsek M., Aldemir M. N., Yildirim N., ÇANKAYA E., ERDEMCİ B., et al.

EURASIAN JOURNAL OF MEDICINE , vol.48, no.1, pp.33-36, 2016 (ESCI, Scopus, TRDizin) Sustainable Development

53. MULTICENTRIC BONE INVOLVEMENT AND COMPLETE RESPONSE TO CHEMOTHERAPY: A CASE REPORT

ŞİMŞEK M., TÜRKELİ M., ALDEMİR M. N., YILDIRIM N., TEKİN S. B., BİLİCİ M.

ACTA MEDICA MEDITERRANEA , vol.32, no.1, pp.163-166, 2016 (SCI-Expanded, Scopus)

54. Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)

Kaplan M. A., Arslan U. Y., Isikdogan A., DANE F., Oksuzoglu B., İNANÇ M., et al.

BREAST CARE , vol.11, no.4, pp.248-252, 2016 (SCI-Expanded, Scopus)

55. Tiroit Kanserinde Tıbbi Tedavi

BİLİCİ M., TEKİN S. B.

Turkiye Klinikleri J Gen Surg-Special Topics , 2016 (Non Peer-Reviewed Journal) Sustainable Development

56. EFFICACY AND TOLERABILITY OF CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC GASTRIC CANCER

TÜRKELİ M., ALDEMİR M. N., ŞİMŞEK M., YILDIRIM N., BİLİCİ M., Cayir K., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , vol.19, no.1, pp.27-34, 2016 (SCI-Expanded, SSCI, Scopus, TRDizin) Sustainable Development

57. Remisyonda ve Takipte Kanser Hastasında BeslenmeNutrition of Cancer Patient in Remission and Follow Up Periods

BİLİCİ M.

Turkiye Klinikleri Journal of Medical Oncology Special Topics , 2016 (Non Peer-Reviewed Journal) Sustainable Development

58. Are We Late at the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients 11 Years Experience

TÜRKELİ M., ŞİMŞEK M., ALDEMİR M. N., YILDIRIM N., ÇANKAYA E., ERDEMCİ B., et al.

Eurasian Journal of Medicine , 2015 (Scopus, TRDizin)

59. Pathologic and Clinical Characteristics of Elderly Patients With Breast Cancer: A Retrospective Analysis of a Multicenter Study (Anatolian Society of Medical Oncology)

Inal A., Akman T., Yaman S., Ozturk S. C., Geredeli C., BİLİCİ M., et al.

INTERNATIONAL SURGERY , vol.99, no.1, pp.2-7, 2014 (SCI-Expanded, Scopus) Sustainable Development

60. Levels of vitamin K3 in healthy volunteers and in patients with different types of stomach cancer after a single vitamin K3 administration

Demirkaya-Miloglu F., KADIOĞLU Y., BİLİCİ M., TEKİN S. B., OZTURK M.

Journal of Liquid Chromatography and Related Technologies , vol.36, no.11, pp.1467-1477, 2013 (SCI-Expanded, Scopus) Sustainable Development

61. Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology

Inal A., Akman T., Yaman S., Ozturk S. C., Geredeli C., BİLİCİ M., et al.

ANNALI ITALIANI DI CHIRURGIA , vol.84, no.2, pp.143-148, 2013 (SCI-Expanded, Scopus) Sustainable Development

62. Investigation of ErbB-2 Overexpression on Patients with Gastric Cancer in Eastern Anatolia of Turkey

Emre H., TEKİN S. B., DOĞAN H., ÇAYIR K., BİLİCİ M., ŞİPAL S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.3, pp.211-217, 2013 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

63. Retrospective analysis of patients with esophageal cancer treated with radiotherapy and/or chemoradiotherapy

Kandaz M., Ertekin M. V., BİLİCİ M.

TUMORI , vol.98, no.4, pp.445-450, 2012 (SCI-Expanded, Scopus) Sustainable Development

64. The evaluation of the results of adjuvant chemoradiotherapy in patients with gastric cancer: results from a single center in eastern Anatolia

BİLİCİ M., TEKİN S. B., KANDAZ M., ÇAYIR K., ERTEKİN M. V., Ozmen H.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.42, no.2, pp.329-336, 2012 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

65. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats.

Bilici M., CAYIR K., Tekin S. B., GUNDOGDU C., Albayrak A., SULEYMAN B., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.13, pp.4897-900, 2012 (SCI-Expanded, Scopus)

66. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.

ONCOLOGY , vol.83, no.3, pp.141-150, 2012 (SCI-Expanded, Scopus) Sustainable Development

67. AN UNUSUAL CAUSE OF CIRRHOSIS: ALVEOLAR ECHINOCOCCOSIS

YILMAZ Ö., DURSUN H., ALBAYRAK F., UYANIK A., KELEŞ M., BİLİCİ M.

NOBEL MEDICUS , vol.7, no.1, pp.106-108, 2011 (SCI-Expanded, Scopus)

68. Relation of antiulcer effect of progesterone resulting from follicle stimulating hormone inhibition with gastric cyclooxygenase levels in female rats

Karaca M., BÖREKÇİ B., KUMTEPE Y., SALMAN S., HACIMÜFTÜOĞLU A., GÜLABOĞLU M., et al.

Asian Journal of Chemistry , vol.22, no.5, pp.3761-3770, 2010 (SCI-Expanded, Scopus)

69. Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers.

SULEYMAN H., Albayrak A., Bilici M., Cadirci E., Halici Z.

Inflammation , vol.33, pp.224-34, 2010 (SCI-Expanded, Scopus)

70. Distribution of HLA Tissue Groups in Patients with Gastric Cancer.

BILICI M., Okcu N., CAYıR K., PIRIM I., TEKIN S., GUNDOGDU C.

The Eurasian journal of medicine , vol.42, pp.9-11, 2010 (SCI-Expanded, TRDizin) Sustainable Development

71. COX-2 Expression in Gastric Cancer

Bekdemir H., Tekin S. B., BİLİCİ M., Cayir K., GÜNDOĞDU C.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.20, no.1, pp.34-41, 2010 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

72. Coping anxiety and depression in Turkish patients with cancer

YILMAZ KARABULUTLU E., BİLİCİ M., ÇAYIR K., TEKİN S. B., KANTARCI R.

European Journal Oof General Medicine , vol.7, pp.296-302, 2010 (Peer-Reviewed Journal) Sustainable Development

73. Relation of adrenergic receptors, which have roles in gastroprotective and anti-inflammatory effect of adrenal gland hormones, with cyclooxygenase enzyme levels in rats

SULEYMAN H., DURSUN H., BİLİCİ M., ÇADIRCI E., HALICI Z., GÜLABOĞLU M., et al.

Journal of Physiology and Pharmacology , vol.60, no.4, pp.129-134, 2009 (SCI-Expanded, Scopus)

74. The Levels of Serum C-Reactive Protein, Beta 2 Microglobulin, Ferritin, Lactate Dehydrogenase and Some Specific Proteins in Patients with Non-Hodgkin’s Lymphoma Before and After Treatment

YILDIRIM R., GÜNDOĞDU M., ERDEM F., KİKİ İ., BİLİCİ M.

EURASIAN JOURNAL OF MEDICINE , vol.41, no.3, pp.165-168, 2009 (TRDizin)

75. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer

Bulut I., Meral M., Kaynar H., Pirim I., BİLİCİ M., Gorguner M.

LUNG CANCER , vol.66, no.2, pp.231-236, 2009 (SCI-Expanded, Scopus) Sustainable Development

76. Protective Effect of Mirtazapine on Indomethacin-Induced Ulcer in Rats and Its Relationship with Oxidant and Antioxidant Parameters

Bilici M., ÖZTÜRK C., DURSUN H., ALBAYRAK F., SAĞLAM M. B., Uyanik A., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.54, no.9, pp.1868-1875, 2009 (SCI-Expanded, Scopus)

77. A case of ichthyosiform sarcoidosis with unusual localization

TEKİN S. B., Cayir K., BİLİCİ M., ŞİPAL S., ATASOY M., TÜRKELİ M.

CENTRAL EUROPEAN JOURNAL OF MEDICINE , vol.4, no.3, pp.388-390, 2009 (SCI-Expanded, Scopus)

78. Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue

DURSUN H., BİLİCİ M., ALBAYRAK F., Ozturk C., SAĞLAM M., ALP H., et al.

BMC GASTROENTEROLOGY , vol.9, 2009 (SCI-Expanded, Scopus)

79. Long-term treatments with low- and high dose olanzapine change hepatocyte numbers in rats. A stereological and histopathological study.

ODACI E., Bilen H., Hacimuftuoglu A., Keles O. N., CAN I., Bilici M.

Archives of medical research , vol.40, pp.139-45, 2009 (SCI-Expanded, Scopus)

80. STEREOLOGICAL AND HISTOLOGICAL ANALYSIS OF THYROID IN 20 DAYS RAT FOETUSES

Altunkaynak M. E., Altunkaynak B. Z., ÜNAL D., Bilici M., CAN İ., VURALER Ö., et al.

IUBMB LIFE , vol.61, no.3, pp.330-331, 2009 (SCI-Expanded, Scopus)

81. Serum Adiponectin Levels in Patients with Esophageal Cancer

YILDIRIM A., BİLİCİ M., Cayir K., Yanmaz V., YILDIRIM S., TEKİN S. B.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.39, no.2, pp.92-96, 2009 (SCI-Expanded, Scopus) Sustainable Development

82. Stereological Evaluation of Tumor Regression Rates in Lung Cancer Using CT Via the Cavalieri Method

AKGÜN M., KANTARCI A., Cayir K., BAYRAKTUTAN Ü., Doganay S., ARAZ Ö., et al.

EURASIAN JOURNAL OF MEDICINE , vol.40, no.3, pp.109-114, 2008 (ESCI, Scopus, TRDizin) Sustainable Development

83. Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer

Dursun H., Bilici M., Uyanik A., Okcu N., AKYÜZ M.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , vol.34, no.2, pp.193-199, 2006 (SCI-Expanded, Scopus) Sustainable Development

84. A GIANT HEMANGIOMA WITH 35 CM IN DIAMETER: A CASE REPORT

YILMAZ Ö., BİLİCİ M., ÇAYIR K.

Eurasian J Med , vol.38, pp.57-59, 2006 (TRDizin)

85. Morphological alterations produced by zinc deficiency in rat sciatic nerve: A histological, electron microscopic, and stereological study

ÜNAL B., Tan H., Orbak Z., Kiki I., Bilici M., BİLİCİ N., et al.

BRAIN RESEARCH , vol.1048, pp.228-234, 2005 (SCI-Expanded, Scopus)

86. Effect of Carotid Stenosis on the Development of Subarachnoid Hemorrhage Eksperimental Study

ATALAY C., BAYRAM E., AYDIN M. D., BİLİCİ M., OKUMUŞ Z., GÜNDOĞDU C.

Turkish Journal Of Medical Sciences , vol.35, pp.379-383, 2005 (Scopus, TRDizin)

Papers Presented at Peer-Reviewed Scientific Conferences 7

1. Kemoterapi Gören Kanser Hastalarında Kahkaha Yogasının Semptomlar, Umut ve Yaşam Katılımı Üzerindeki Etkisi: Disiplinlerarası Rastgele Kontrollü Çalışma

Çıracı Yaşar Y., Tan M., Bilici M.

2. Uluslararası Hemşirelik Çalışmaları Kongresi, Ordu, Turkey, 3 - 06 September 2025, pp.26, (Summary Text)

2. Geriatrik yaş, opere nüks mide kanserinde uzun süreli kapesitabin kullanımı

ÇOBAN EŞDUR P., BİLİCİ M., TEKİN S. B.

6.geriatrik onkoloji kongresi, 8 - 10 October 2024, (Full Text)

3. Pathological complete response to FLOT chemotherapy with/without durvalumab in resectable gastric and gastroesophageal junction cancer:subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

Janjigian Y. Y., Al-Batran S., Wainberg Z. A., Van Cutsem E., Molena D., Muro K., et al.

Annual Meeting of the Society-of-Surgical-Oncology (SSO), Georgia, United States Of America, 20 - 23 March 2024, (Summary Text)

Books 1

1. Jinekolojik Tümörler El Kitabı Tanı Tedavi Takip Tedavi Algoritmalarının Oluşturulması

BİLİCİ M., AYDINER A., BİLİCİ A., KİZİR A., Ağaoğlu A., SEZER Y. A., et al.

Nobel Tıp Kitapevleri, İstanbul, 2016

Metrics

Publication

122

Publication (WoS)

Publication (Scopus)

Citation (WoS)

1185

H-Index (WoS)

Citation (Scopus)

1608

H-Index (Scopus)

Citation (Scholar)

651

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING

SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS

Publications & Works